This is significant because MASLD/MASH affects an estimated 30% of the global population, and we currently have very limited pharmacological options
Also, does not measure muscle mass, body composition, or hormonal problems
[PMID: 3191136] PubMed record related to this compound for laboratory literature review
Wellpath targets that cycle using a metabolic trio: berberine for GLP-1 release, apple-cider-vinegar powder to slow stomach emptying, and Ceylon cinnamon to sharpen insulin response
This means that 67 people with (severe) cardiovascular risk need to be on Wegovy consistently to avoid one cardiovascular event, for example, a heart attack
Diet quality also matters - try the Mediterranean or DASH eating plan